Loading...
•
Dec 31, 2019
ICU Medical Q4 2019 Earnings Report
ICU Medical's fourth quarter results reflected a decrease in revenue compared to the same period last year, but net income improved significantly.
Key Takeaways
ICU Medical reported a revenue of $315.5 million for Q4 2019, a decrease from $340.4 million in Q4 2018. However, the company's net income increased to $20.6 million, or $0.96 per diluted share, compared to a net loss of $7.4 million, or $0.36 loss per diluted share, in the same period last year. Adjusted diluted earnings per share were $1.94, and adjusted EBITDA was $60.7 million.
Q4 2019 revenue was $315.5 million, down from $340.4 million year-over-year.
GAAP net income was $20.6 million, or $0.96 per diluted share, compared to a net loss of $7.4 million, or $0.36 loss per diluted share, in Q4 2018.
Adjusted diluted earnings per share were $1.94, compared to $2.14 in the same period last year.
Adjusted EBITDA was $60.7 million, compared to $69.3 million in the prior year.
Revenue by Segment
Forward Guidance
For the Fiscal Year 2020, the Company expects adjusted EBITDA to be in the range of $240 million to $260 million, and adjusted diluted EPS to be in the range of $6.50 to $7.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...